Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Healthcare | 2.2% |
| 4 | Financials | 2.18% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVV
3651
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
| $6.73M | ﹤0.01% |
+510,668
| New | +$6.78M |
|
3652
CALL
Immunovant
IMVT
$8B
| $6.72M | ﹤0.01% |
773,600
-108,700
| -12% | -$981K |
|
3653
CALL
Verisk Analytics
VRSK
$24.5B
| $6.71M | ﹤0.01% |
33,500
-19,900
| -37% | -$3.86M |
|
3654
CALL
National Beverage
FIZZ
$2.99B
| $6.7M | ﹤0.01% |
127,700
-73,800
| -37% | -$3.43M |
|
|
MRTX
3655
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.7M | ﹤0.01% |
37,890
-419,707
| -92% | -$67.5M |
|
3656
Kymera Therapeutics
KYMR
$8.66B
| $6.69M | ﹤0.01% |
113,928
+51,440
| +82% | +$2.98M |
|
3657
PUT
ProShares Ultra Bloomberg Natural Gas
BOIL
$348M
| $6.69M | ﹤0.01% |
407
+230
| +130% | +$2.27M |
|
|
STMP
3658
DELISTED
Stamps.com, Inc.
STMP
| $6.69M | ﹤0.01% |
20,276
-4,430
| -18% | -$1.41M |
|
3659
CALL
LGI Homes
LGIH
$1.43B
| $6.68M | ﹤0.01% |
47,100
-10,800
| -19% | -$1.71M |
|
|
WEBR
3660
CALL
DELISTED
Weber Inc.
WEBR
| $6.68M | ﹤0.01% |
+380,000
| New | +$6.1M |
|
|
SNV
3661
CALL
DELISTED
Synovus
SNV
| $6.68M | ﹤0.01% |
152,200
+60,100
| +65% | +$2.54M |
|
|
B
3662
DELISTED
Barnes Group Inc.
B
| $6.67M | ﹤0.01% |
159,865
+137,656
| +620% | +$6.56M |
|
3663
CALL
Amplify Alternative Harvest ETF
MJ
$100M
| $6.67M | ﹤0.01% |
38,617
-11,008
| -22% | -$2.25M |
|
|
MDP
3664
CALL
DELISTED
Meredith Corporation
MDP
| $6.67M | ﹤0.01% |
119,700
+32,500
| +37% | +$1.42M |
|
3665
JPMorgan Equity Premium Income ETF
JEPI
$45.7B
| $6.66M | ﹤0.01% |
111,798
+71,968
| +181% | +$4.43M |
|
3666
iShares GNMA Bond ETF
GNMA
$423M
| $6.66M | ﹤0.01% |
133,301
-254,235
| -66% | -$12.7M |
|
|
AGNT
3667
CALL
AGNT Inc
AGNT
$659M
| $6.66M | ﹤0.01% |
167,500
-35,200
| -17% | -$1.51M |
|
3668
Spire Global
SPIR
$499M
| $6.66M | ﹤0.01% |
+68,367
| New | +$5.76M |
|
|
HBI
3669
CALL
DELISTED
Hanesbrands
HBI
| $6.66M | ﹤0.01% |
387,900
+51,800
| +15% | +$971K |
|
3670
CALL
Zions Bancorporation
ZION
$10.4B
| $6.65M | ﹤0.01% |
107,400
-11,500
| -10% | -$632K |
|
3671
CALL
Cirrus Logic
CRUS
$6.6B
| $6.65M | ﹤0.01% |
80,700
-12,600
| -14% | -$1.05M |
|
3672
Arista Networks
ANET
$249B
| $6.64M | ﹤0.01% |
308,960
-1,313,200
| -81% | -$30.1M |
|
3673
iShares US Aerospace & Defense ETF
ITA
$14.7B
| $6.63M | ﹤0.01% |
63,640
+13,844
| +28% | +$1.47M |
|
3674
PUT
Inovio Pharmaceuticals
INO
$70M
| $6.63M | ﹤0.01% |
77,175
+32,350
| +72% | +$3.25M |
|
3675
Designer Brands
DBI
$341M
| $6.63M | ﹤0.01% |
475,817
+212,404
| +81% | +$3.07M |
|
Similar funds
Citadel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
- Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.